# Pharmacokinetics Profile Study of BG00012 Standard Formulation and BG00012 Active Pharmaceutical Ingredient

> **NCT01069913** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BG00012

## Key facts

- **NCT ID:** NCT01069913
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2009-10
- **Final completion:** 2010-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2010-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01069913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01069913, "Pharmacokinetics Profile Study of BG00012 Standard Formulation and BG00012 Active Pharmaceutical Ingredient". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01069913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*